About us

MACS® Technology – at the core of Miltenyi Biotec

Viable cells for cell and gene therapy

Gentle to cells

MACS Technology owes its longstanding success to the combination of superparamagnetic nano-sized beads and a very high magnetic gradient within our MACS Columns. This combination allows for minimal labeling of target cells and therefore preservation of cell integrity and characteristics. MACS MicroBeads are biodegradable and compatible with all downstream applications, including cell sorting, flow cytometry, cell culture, functional assays, and molecular analyses.

Advantages of MACS Technology over column-free cell isolation techniques

Related PDFs:

Maximum purity and yield of viable cells

To facilitate translation into clinical settings, cell isolation procedures need to produce sufficient amounts of pure, viable cells.

FDA approval in 2014 – bringing MACS Technology into the clinic

CliniMAS® CD34 Reagent System

  • FDA-approved method for selecting hematopoietic stem cells from donor apheresis, while passively depleting T cells that can cause graft-versus-host disease (GVHD)
  • Treatment of patients with acute myeloid leukemia (AML) in first complete remission
  • Annually, more than 2,500 patients receive cell products manufactured with Miltenyi Biotec technologies